Professor Mark Wilcox
Infection Diagnostics Theme Lead
Professor Mark Wilcox is a Consultant Microbiologist, Head of Research and Development in Microbiology at the Leeds Teaching Hospitals (LTHT), Professor of Medical Microbiology at the University of Leeds (Leeds Institute of Biomedical and Clinical Sciences), and is the Lead on Clostridium difficile & Head of the UK C. difficile Reference Laboratory for Public Health England (PHE). Medical Advisor to National Infection Prevention & Control Lead (NHS Improvement), England. He has formerly been the Director of Infection Prevention (4 years), Infection Control Doctor (8 years), Clinical Director of Pathology (6 years) at LTHT and Head of Microbiology (15 years).
MW is Chair of PHE’s Rapid Review Panel (reviews the utility of infection prevention & control products for the NHS), and Deputy Chair of the UK Department of Health’s Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Committee. From 2017, he has been seconded one day per week to NHS Improvement to support the delivery of the new national target to reduce healthcare associated Gram-negative blood stream infections in England.
Professor Wilcox heads a Healthcare Associated Infection research team at the University of Leeds (http://medhealth.leeds.ac.uk/hcai); projects include multiple aspects of Clostridium difficile infection, diagnostics, antibiotic resistance and the gut microbiome, staphylococcal infection, and the clinical development of new antimicrobial agents.